Gute Nachrichten · aus aller Welt · jeden Tag

Brightside

On the front page we count who comes last. Here we show what vorangeht. Only constructive news – and nothing without evidence. Every item names its source and date and links the original. Good news deserves the same fact-checking as bad news.

backed by sources worldwide curated daily only constructive
Transparenz: Diese Seite zeigt only verifiable, positive developments. Every item comes with its original source and datum versehen. How we select and update →

In the light today

As of: September 12, 2026
Economy · Europe

German export expectations hit a four-year high

German export expectations climbed to their strongest level in four years in August, pointing to a clearer improvement in business sentiment after a long weak stretch. The rebound was helped by government-backed investment and wider use of artificial intelligence.

The signal is encouraging, but it is still a survey measure rather than a hard trade figure, so it shows confidence more than guaranteed export growth.

Source: AI-researched

4-year high
German export expectations reached their highest level since February 2022, according to the Ifo survey reported by Reuters.

What gives hope this week

7 belegte Meldungen · alle Bereiche
Health

Uganda’s Ebola outbreak has ended

The World Health Organization said the Ebola outbreak in Uganda is over after 20 cases and 2 deaths, showing that rapid containment can work even in a difficult regional outbreak.

The wider Congo outbreak remains active, so the public-health progress is real, but the risk has not disappeared.

Source: Reuters · August 2026
Climate & Energy

Renewable energy is gaining fresh momentum

Reuters reported that governments in Europe and Asia are accelerating renewable power projects, and the International Energy Agency expects renewable electricity to become the world’s top source this year.

The transition is advancing, but the IEA still expects global energy-related emissions to rise 1.1% this year to a record 14.2 billion tonnes.

Source: Reuters · August 2026
Science & Technology

Cancer vaccine trial cuts melanoma recurrence risk

Moderna and Merck said their personalized mRNA cancer vaccine reduced the risk of melanoma returning and spreading in a late-stage trial. Reuters reported that the study involved more than 1,000 patients, marking a major step for individualized cancer treatment.

Source: Reuters · August 2026

// Transparency & method

How we select – and how this page is kept up to date

1 Sources required

No item without a verifiable primary source. We prefer originals: WHO, IEA, IUCN, UN, World Bank, peer-reviewed journals and official statistics offices. Every entry names its source and date and links to the original.

2 Nur Konstruktives

Only verifiable progress appears here – but never whitewashed. Where a piece of good news has a "but" (such as funding gaps), we say so instead of wegzulassen.

3 Daily update

The selection is maintained daily from a fixed list of trustworthy sources. Only what has been checked against the original gets published – automation does not replace verification.

Full disclosure: This page is generated fully automatically by AI-assisted research with web search (as of this edition: August 31, 2026). Every item must cite a real, linked source (WHO, IEA, IUCN, UN, World Bank, peer-reviewed journals, etc.) — no manual editorial review takes place before publication. Found an error? Write to hallo@schlusslicht.de — we correct transparently.